home / stock / mtnb / mtnb quote
Last: | $0.169 |
---|---|
Change Percent: | 3.74% |
Open: | $0.1629 |
Close: | $0.1629 |
High: | $0.169 |
Low: | $0.1601 |
Volume: | 415,087 |
Last Trade Date Time: | 07/25/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.169 | $0.1629 | $0.1629 | $0.169 | $0.1601 | 415,087 | 07-25-2024 |
$0.1629 | $0.168 | $0.1629 | $0.168 | $0.1601 | 378,113 | 07-24-2024 |
$0.1686 | $0.1607 | $0.1686 | $0.1691 | $0.158 | 511,344 | 07-23-2024 |
$0.1577 | $0.1765 | $0.1577 | $0.1818 | $0.1538 | 2,764,337 | 07-22-2024 |
$0.1793 | $0.187 | $0.1793 | $0.187 | $0.17 | 776,134 | 07-19-2024 |
$0.1794 | $0.1825 | $0.1794 | $0.1878 | $0.1781 | 382,052 | 07-18-2024 |
$0.1826 | $0.19 | $0.1826 | $0.19 | $0.175 | 592,334 | 07-17-2024 |
$0.1865 | $0.1862 | $0.1865 | $0.192 | $0.1773 | 2,051,112 | 07-16-2024 |
$0.1826 | $0.17 | $0.1826 | $0.1891 | $0.1698 | 2,567,219 | 07-15-2024 |
$0.1698 | $0.167 | $0.1698 | $0.17 | $0.166 | 592,500 | 07-12-2024 |
$0.1666 | $0.1731 | $0.1666 | $0.1731 | $0.163 | 743,674 | 07-11-2024 |
$0.1689 | $0.16 | $0.1689 | $0.17 | $0.16 | 773,868 | 07-10-2024 |
$0.163 | $0.1636 | $0.163 | $0.1636 | $0.1603 | 530,005 | 07-09-2024 |
$0.1635 | $0.163 | $0.1635 | $0.1676 | $0.163 | 393,685 | 07-08-2024 |
$0.167 | $0.1602 | $0.167 | $0.167 | $0.16 | 631,394 | 07-05-2024 |
$0.1602 | $0.1589 | $0.1602 | $0.1608 | $0.1576 | 752,393 | 07-04-2024 |
$0.1602 | $0.1589 | $0.1602 | $0.1608 | $0.1576 | 752,393 | 07-03-2024 |
$0.1572 | $0.163 | $0.1572 | $0.163 | $0.153 | 523,769 | 07-02-2024 |
$0.1607 | $0.1601 | $0.1607 | $0.1664 | $0.1555 | 801,087 | 07-01-2024 |
$0.1583 | $0.167 | $0.1583 | $0.167 | $0.1583 | 625,727 | 06-28-2024 |
News, Short Squeeze, Breakout and More Instantly...
Matinas Biopharma Holdings Inc. Company Name:
MTNB Stock Symbol:
NYSE Market:
Matinas Biopharma Holdings Inc. Website:
BEDMINSTER, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology, announces the recent successful...
BEDMINSTER, N.J., June 13, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology, announces that MAT2203, its ora...
BEDMINSTER, N.J., May 16, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology, announces new in vitro data ...